Get the Stockscreener App
39.95
2.46%
0.96
After Hours:
39.95
Sol Gel Technologies Ltd stock is traded at $39.95, with a volume of 13,096.
It is up +2.46% in the last 24 hours and up +61.02% over the past month.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
See More
Previous Close:
$38.99
Open:
$39.45
24h Volume:
13,096
Relative Volume:
0.59
Market Cap:
$111.29M
Revenue:
$23.93M
Net Income/Loss:
$-3.41M
P/E Ratio:
-35.04
EPS:
-1.14
Net Cash Flow:
$-33.87M
1W Performance:
-6.88%
1M Performance:
+61.02%
6M Performance:
+829.07%
1Y Performance:
+487.50%
1-Day Range:
$37.60
$40.45
1-Week Range:
$34.80
$46.71
52-Week Range:
$4.006
$52.26
Sol Gel Technologies Ltd Stock (SLGL) Company Profile
Name
Sol Gel Technologies Ltd
Sector
Industry
Phone
-
Address
-
Compare SLGL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLGL
Sol Gel Technologies Ltd
|
39.95 | 108.62M | 23.93M | -3.41M | -33.87M | -1.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-21-22 | Resumed | Jefferies | Hold |
| Dec-31-19 | Reiterated | H.C. Wainwright | Buy |
| Dec-31-19 | Reiterated | JMP Securities | Mkt Outperform |
Sol Gel Technologies Ltd Stock (SLGL) Latest News
Has Sol Gel Technologies Ltd. formed a bullish divergenceExit Point & AI Enhanced Trading Alerts - newser.com
Does Sol Gel Technologies Ltd. qualify in momentum factor screeningQuarterly Profit Report & Real-Time Volume Analysis - newser.com
Momentum divergence signals in Sol Gel Technologies Ltd. chartPortfolio Update Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Risk adjusted return profile for Sol Gel Technologies Ltd. analyzedEntry Point & Stock Market Timing Techniques - newser.com
Technical analysis overview for Sol Gel Technologies Ltd. stockJuly 2025 PostEarnings & Technical Confirmation Alerts - newser.com
Is Sol Gel Technologies Ltd. (4SG) stock attractive for dividend growthWeekly Trade Review & AI Forecast Swing Trade Picks - newser.com
Why Sol Gel Technologies Ltd. stock attracts global investorsTrade Risk Summary & Technical Pattern Alert System - newser.com
Why Sol Gel Technologies Ltd. stock is trending among retail traders2025 Analyst Calls & Safe Entry Point Alerts - newser.com
Is Sol Gel Technologies Ltd. forming a reversal patternQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
How moving averages guide Sol Gel Technologies Ltd. tradingQuarterly Profit Summary & Weekly Watchlist of Top Performers - newser.com
Can you recover from losses in Sol Gel Technologies Ltd.July 2025 Gainers & Safe Capital Growth Stock Tips - newser.com
Will earnings trigger a reversal in Sol Gel Technologies Ltd.Quarterly Performance Summary & Fast Moving Trade Plans - newser.com
Combining machine learning predictions for Sol Gel Technologies Ltd.Index Update & AI Driven Stock Movement Reports - newser.com
Sol-Gel Technologies (NASDAQ:SLGL) Receives "Hold (C-)" Rating from Weiss Ratings - MarketBeat
Teva Pharmaceutical Industries (NYSE:TEVA) versus Sol-Gel Technologies (NASDAQ:SLGL) Head-To-Head Survey - Defense World
How to forecast Sol Gel Technologies Ltd. trends using time series2025 EndofYear Setup & Verified Momentum Stock Alerts - newser.com
How Sol Gel Technologies Ltd. (4SG) stock benefits from digital adoptionWeekly Stock Summary & Weekly High Potential Alerts - newser.com
How Sol Gel Technologies Ltd. (4SG) stock reacts to monetary easing2025 Support & Resistance & Safe Swing Trade Setups - newser.com
Will Sol Gel Technologies Ltd. (4SG) stock issue positive guidanceQuarterly Risk Review & Weekly Return Optimization Alerts - newser.com
Can a trend reversal in Sol Gel Technologies Ltd. lead to recoveryJuly 2025 PostEarnings & Weekly Chart Analysis and Guides - newser.com
Detecting support and resistance levels for Sol Gel Technologies Ltd.July 2025 Closing Moves & AI Powered Buy/Sell Recommendations - newser.com
Where to Find Annual Report of CompaniesVolatility Adjusted Trading & Superior Trading Ideas - earlytimes.in
Sol Gel Technologies Ltd Stock (SLGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):